{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:45:35Z","timestamp":1792021535645,"version":"4.4.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ctrv.2026.103225","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:01:40Z","timestamp":1791561700000},"page":"103225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CDH1 germline carriers and diffuse gastric Cancer: Are we ready for personalized surveillance and prevention?"],"prefix":"10.1016","volume":"151","author":[{"given":"Mara","family":"Cruellas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Castillo-Iturra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian V.","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Momblan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2026.103225_bb0005","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin; 74(3):229-263. doi:https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103225_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5230\/jgc.2025.25.e16","article-title":"Environmental protective and risk factors for gastric cancer: an umbrella review and reanalysis of meta-analyses","author":"Kim","year":"2025","journal-title":"J Gastric Cancer"},{"key":"10.1016\/j.ctrv.2026.103225_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101846","article-title":"The metastatic pattern of intestinal and diffuse type gastric carcinoma - a Dutch national cohort study","volume":"69","author":"Koemans","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103225_bb0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.34780","article-title":"Peritoneal metastases from gastric cancer in a nationwide cohort: incidence, treatment and survival","volume":"154","author":"Rijken","year":"2024","journal-title":"Int J Cancer"},{"issue":"21","key":"10.1016\/j.ctrv.2026.103225_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10214882","article-title":"The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival","volume":"10","author":"Rijken","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103225_bb0030","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4251\/wjgo.v12.i5.569","article-title":"Gastric cancer with peritoneal metastases: efficiency of standard treatment methods","volume":"12","author":"Yarema","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.21037\/jgo.2017.01.10","article-title":"Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis","volume":"8","author":"Petrelli","year":"2017","journal-title":"J Gastrointest Oncol"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103225_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/atm-20-7953","article-title":"Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a surveillance, epidemiology, and end results (SEER)-based cohort study","volume":"9","author":"Tang","year":"2021","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0045","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1005693","article-title":"Analysis of clinicopathological features, treatment modalities, and survival outcomes in advanced gastric and colorectal signet ring cell carcinoma","volume":"17","author":"Xu","year":"2025","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103225_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10120-018-0860-8","article-title":"Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer","volume":"22","author":"Kao","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.ctrv.2026.103225_bb0055","article-title":"Prevalence of pathogenic germline variants in patients with gastric Cancer ascertained through multigene panel testing","volume":"9","author":"Gilad","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2026.103225_bb0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41416-021-01673-7","article-title":"CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer","volume":"126","author":"Adib","year":"2022","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ctrv.2026.103225_bb0065","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2019.1208","article-title":"Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers","volume":"5","author":"Roberts","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0070","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","article-title":"Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria","volume":"56","author":"Xicola","year":"2019","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"issue":"21","key":"10.1016\/j.ctrv.2026.103225_bb0080","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1001\/jama.297.21.2360","article-title":"Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer","volume":"297","author":"Kaurah","year":"2007","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103225_bb0085","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctrv.2026.103225_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.10852","article-title":"Germline CDH1 variants and lifetime cancer risk","author":"Ryan","year":"2024","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103225_bb0095","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1016\/S1470-2045(20)30219-9","article-title":"Hereditary diffuse gastric cancer: updated clinical practice guidelines","volume":"21","author":"Blair","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(22)00643-X","article-title":"Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European reference network on genetic tumour risk syndromes","volume":"24","author":"Garcia-Pelaez","year":"2023","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0105","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/annonc\/mdg486","article-title":"The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice","volume":"14","author":"Graziano","year":"2003","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103225_bb0110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/path.6277","article-title":"Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer","volume":"263","author":"Monster","year":"2024","journal-title":"J Pathol"},{"key":"10.1016\/j.ctrv.2026.103225_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddaf092","article-title":"Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis","author":"Corso","year":"2025","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103225_bb0120","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/gutjnl-2024-334589","article-title":"Tumour-intrinsic alterations and stromal matrix remodelling promote Wnt-niche independence during diffuse-type gastric cancer progression","volume":"74","author":"Kemp","year":"2025","journal-title":"Gut"},{"issue":"55","key":"10.1016\/j.ctrv.2026.103225_bb0125","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1038\/onc.2008.343","article-title":"Cadherins and cancer: how does cadherin dysfunction promote tumor progression?","volume":"27","author":"Jeanes","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2026.103225_bb0130","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2920493","article-title":"Loss of LLGL1 expression correlates with diffuse gastric cancer and distant peritoneal metastases","volume":"2019","author":"Desuki","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103225_bb0135","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-07-2938","article-title":"Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways","volume":"68","author":"Onder","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103225_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00438","article-title":"RHOA in gastric cancer: functional roles and therapeutic potential","volume":"10","author":"Nam","year":"2019","journal-title":"Front Genet"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0145","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1541-7786.MCR-23-0122","article-title":"Early immune changes support signet ring cell dormancy in CDH1-driven hereditary diffuse gastric carcinogenesis","volume":"21","author":"Green","year":"2023","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ctrv.2026.103225_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.70044","article-title":"Performance of upper gastrointestinal endoscopy in CDH1 germline pathogenic variant carriers: a multicenter study","author":"Castillo-Iturra","year":"2025","journal-title":"Intl Journal of Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1470-2045(22)00700-8","article-title":"Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study","volume":"24","author":"Lee","year":"2023","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103225_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1470-2045(23)00057-8","article-title":"Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study","volume":"24","author":"Asif","year":"2023","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2026.103225_bb0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jmg-2025-111222","article-title":"Expert endoscopic surveillance in CDH1 pathogenic variant carriers seems safe, even after positive (pT1a) biopsies","volume":"63","author":"Benusiglio","year":"2026","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103225_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1470-2045(23)00094-3","article-title":"Endoscopic surveillance: time for a paradigm shift in hereditary diffuse-type gastric cancer management?","volume":"24","author":"van der Post","year":"2023","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103225_bb0175","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cgh.2019.06.009","article-title":"Optimal timing of Total gastrectomy to prevent diffuse gastric Cancer in individuals with pathogenic variants in CDH1","volume":"18","author":"Laszkowska","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103225_bb0180","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/jso.27603","article-title":"Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers","volume":"129","author":"Corso","year":"2024","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2026.103225_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/jso.27855","article-title":"A systematic review of surgical and pathological outcomes in patients with a CDH1 mutation undergoing total gastrectomy","author":"Khiabany","year":"2024","journal-title":"J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2026.103225_bb0190","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamasurg.2020.3356","article-title":"Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies","volume":"155","author":"Vos","year":"2020","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0195","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1007\/s00464-023-10303-7","article-title":"Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers","volume":"37","author":"Bryant","year":"2023","journal-title":"Surg Endosc"},{"issue":"6","key":"10.1016\/j.ctrv.2026.103225_bb0200","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/his.13715","article-title":"Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management","volume":"73","author":"Rocha","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103225_bb0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jmg-2022-108733","article-title":"Decision-making and regret in patients with germline CDH1 variants undergoing prophylactic total gastrectomy","volume":"60","author":"Gamble","year":"2023","journal-title":"J Med Genet"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103225_bb0210","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10897-016-0045-8","article-title":"The psychosocial impact of undergoing prophylactic Total gastrectomy (PTG) to manage the risk of hereditary diffuse gastric Cancer (HDGC)","volume":"26","author":"Hallowell","year":"2017","journal-title":"J Genet Couns"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.annonc.2022.10.004","article-title":"Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO clinical practice guideline","volume":"34","author":"Sessa","year":"2023","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0220","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/jpm12122032","article-title":"Hereditary diffuse gastric Cancer: a 2022 update","volume":"12","author":"Kole","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.ctrv.2026.103225_bb0225","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3389\/fphar.2018.01421","article-title":"CDH1 gene and Hereditary diffuse gastric Cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment","volume":"9","author":"Luo","year":"2018","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.ctrv.2026.103225_bb0230","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.3748\/wjg.v20.i12.3265","article-title":"Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids","volume":"20","author":"Tsujiura","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ctrv.2026.103225_bb0235","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920967238","article-title":"Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell","volume":"12","author":"El Rami","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2026.103225_bb0240","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1053\/j.gastro.2009.02.065","article-title":"Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression","volume":"136","author":"Oliveira","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ctrv.2026.103225_bb0245","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1940-6207.CAPR-23-0449","article-title":"Stool protein mass spectrometry identifies biomarkers for early detection of diffuse-type gastric Cancer","volume":"17","author":"Ho","year":"2024","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103225_bb0250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/annonc\/mdm493","article-title":"Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients","volume":"19","author":"Muretto","year":"2008","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2026.103225_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040953","article-title":"Analysis of extracellular vesicles in gastric juice from gastric cancer patients","volume":"20","author":"Kagota","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103225_bb0260","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1245\/s10434-009-0598-y","article-title":"CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer?","volume":"16","author":"Ziogas","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2026.103225_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05350-2","article-title":"Liquid biopsy in gastric cancer: predictive and prognostic biomarkers","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"0","key":"10.1016\/j.ctrv.2026.103225_bb0265","article-title":"Hereditary diffuse gastric cancer","volume":"0","author":"Decourtye-Espiard","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctrv.2026.103225_bb0275","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41698-024-00694-8","article-title":"Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103225_bb0280","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.5675","article-title":"Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing","volume":"254","author":"Dixon","year":"2021","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ctrv.2026.103225_bb0285","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/gutjnl-2011-300050","article-title":"Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer","volume":"61","author":"Shimada","year":"2012","journal-title":"Gut"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737226001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:50:16Z","timestamp":1792018216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737226001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":57,"alternative-id":["S0305737226001398"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103225","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CDH1 germline carriers and diffuse gastric Cancer: Are we ready for personalized surveillance and prevention?","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2026.103225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103225"}}